Search alternatives:
significantly enhanced » significantly influenced (Expand Search), significantly reduced (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
significantly enhanced » significantly influenced (Expand Search), significantly reduced (Expand Search)
side decrease » sizes decrease (Expand Search), fid decreased (Expand Search), step decrease (Expand Search)
we decrease » _ decrease (Expand Search), a decrease (Expand Search), nn decrease (Expand Search)
-
141
-
142
-
143
-
144
-
145
-
146
-
147
Data for Fig 6D.
Published 2024“…<div><p>Pseudorabies virus (PRV) infection causes systemic inflammatory responses and inflammatory damages in infected animals, which are associated with the activation of inflammasome and pyroptosis in infected tissues. Here, we identified a critical function of PRV non-structural protein UL4 that enhanced ASC-dependent inflammasome activation to promote pyroptosis. …”
-
148
Data for Fig 5D.
Published 2024“…<div><p>Pseudorabies virus (PRV) infection causes systemic inflammatory responses and inflammatory damages in infected animals, which are associated with the activation of inflammasome and pyroptosis in infected tissues. Here, we identified a critical function of PRV non-structural protein UL4 that enhanced ASC-dependent inflammasome activation to promote pyroptosis. …”
-
149
Data for Figs 8A–8H, 9A–9K, 10A–10I.
Published 2024“…<div><p>Pseudorabies virus (PRV) infection causes systemic inflammatory responses and inflammatory damages in infected animals, which are associated with the activation of inflammasome and pyroptosis in infected tissues. Here, we identified a critical function of PRV non-structural protein UL4 that enhanced ASC-dependent inflammasome activation to promote pyroptosis. …”
-
150
-
151
Characterization of systolic pulmonary arterial pressure (sPAP) of WT BMP9 in rats.
Published 2025Subjects: -
152
Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i>
Published 2025Subjects: -
153
-
154
Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode.
Published 2025Subjects: -
155
-
156
Evaluation of chronic <i>in vivo</i> efficacy in 21 days rat MCT model in prevention mode.
Published 2025Subjects: -
157
-
158
Pharmacological characterization of WT BMP9 and A347E variant <i>in vitro</i> and <i>in vivo.</i>
Published 2025Subjects: -
159
-
160